Clinical Trials Browser

Phase 2 × OTHER × dupilumab × Clear all

NCT05967884 2023-08-01

PD-1 +/- IL-4 Inhibition in ER+ Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT03886493 2021-10-15

Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer

Phase 2 Terminated

7 enrolled 7 charts

Prostatic Neoplasms